Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
apoQlar
Hamburg, Hamburg, Germany
- Ownership
- Private
- Development stage
- Other
01
Overview
apoQlar's VSI HoloMedicine® platform is CE marked, FDA 510(k) cleared, and commercially available for medical imaging, surgical planning, and medical education. The technology allows for 3D visualization of radiological images and is in active use at over 60+ medical institutions, with positive feedback from healthcare professionals and academic users.[1][2][3][6][7]
- Therapeutic areas
- OncologyOther
- Modalities
- DeviceSoftware
- Industry
- Medical Imaging
02
Partnerships
Mayo ClinicNational University Health System (NUHS)SingtelInfocomm Media Development Authority (IMDA)Microsoft
Beyond the preview
Go deeper on apoQlar.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on apoQlar.